ABC | Volume 111, Nº3, September 2018

Original Article Nemes et al RA function in CA by 3DSTE Arq Bras Cardiol. 2018; 111(3):384-391 This is an open-access article distributed under the terms of the Creative Commons Attribution License 21. Dispenzieri A, Gertz MA, Kyle RA, Lacy MQ, Burritt MF, Therneau TM, et al. SerumcardiactroponinsandN-terminalpro–brainnatriureticpeptide:astaging system for primary systemic amyloidosis. J ClinOncol. 2004;22(18):3751-7. 22. Patel AR, Dubrey SW, Mendes LA, Skinner M, Cupples A, Falk RH, et al. Right ventricular dilation in primary amyloidosis: an independent predictor of survival. Am J Cardiol. 1997;80(4):486-92. 23. Porciani MC, Lilli A, Perfetto F, Cappelli F, Massimiliano Rao C, Del Pace S, et al. Tissue Doppler and strain imaging: a new tool for early detection of cardiac amyloidosis. Amyloid. 2009;16(2):63-70. 24. Tsang W, Lang RM. Echocardiographic evaluation of cardiac amyloid. Curr Cardiol Rep. 2010;12(3):272-6. 25. Bellavia D, Pellikka PA, Abraham TP, Al-Zahrani GB, Dispenzieri A, Oh JK, et al. Evidence of impaired left ventricular systolic function by Doppler myocardial imaging in patients with systemic amyloidosis and no evidence of cardiac involvement by standard two-dimensional and Doppler echocardiography. Am J Cardiol. 2008;101(7):1039-45. 26. Bellavia D, Pellikka PA, Dispenzieri A, Scott CG, Al-Zahrani GB, Grogan M, et al.Comparisonofrightventricular longitudinalstrainimaging,tricuspidannular plane systolic excursion, and cardiac biomarkers for early diagnosis of cardiac involvement and risk stratification in primary systematic (AL) amyloidosis: a 5-year cohort study. Eur Heart J Cardiovasc Imaging. 2012;13(8):680-9. 27. SzczygiełJA,WieczorekPZ,Drozd-SokołowskaJ,MichałekP,MazurkiewiczŁ, Legatowicz-KoprowskaM,etal.Impairedrightventricularfunctionasapredictor of early mortality in patients with light‑chain cardiac amyloidosis assessed in a cardiology department. Pol Arch InternMed. 2017;127(12):854-64. 28. FöldeákD,KormányosÁ,DomsikP,KalaposA,PirosGÁ,AmbrusN,etal.Leftatrial dysfunctioninlight-chaincardiacamyloidosisandhypertrophiccardiomyopathy -Acomparativethree-dimensionalspeckle-trackingechocardiographicanalysis fromtheMAGYAR-PathStudy.RevPortCardiol.2017;36(12):905-13. 391